CNS pipeline · person
Rory B. Riggs
Director of Intra-Cellular Therapies since January 2014. He is Chairman and CEO of the agricultural gene-editing company Cibus (NASDAQ: CBUS) and a co-founder and director of Royalty Pharma (NASDAQ: RPRX). He previously served as President and director of Biomatrix until its sale to Genzyme Biosurgery, and holds a B.A. from Middlebury College and an M.B.A. from Columbia University.
- 1 company
Current roles
- Intra-Cellular Therapies, Inc.Director · Board2014–present
Appears with
People sharing a company with Rory.
- E. Rene Salas · Intra-Cellular Therapies, Inc.
- Joel S. Marcus · Intra-Cellular Therapies, Inc.
- Lawrence J. Hineline · Intra-Cellular Therapies, Inc.
- Mark Neumann · Intra-Cellular Therapies, Inc.
- Michael I. Halstead · Intra-Cellular Therapies, Inc.
- Robert L. Van Nostrand · Intra-Cellular Therapies, Inc.
- Sharon Mates · Intra-Cellular Therapies, Inc.
- Suresh Durgam · Intra-Cellular Therapies, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.